Fidelity Investments’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
O
VPC
NLVP
EAM
TCM
Fidelity Investments's PASG Position: Q1 2025 in Review
Fidelity Investments sold out of Passage Bio (PASG) in Q1 2025, closing a stake of 1,053 shares — an estimated $11.9K sold.
Fidelity Investments first reported a position in PASG in Q1 2020 and held it in 20 quarters. The position peaked at $141M in Q1 2021. 41 funds tracked by Wall St. Rank hold PASG as of Q1 2025.
- Fidelity Investments reported no remaining Passage Bio position as of Q1 2025 after selling out during the quarter.
- Fidelity Investments sold 1,053 Passage Bio shares in Q1 2025, an estimated $11.9K.
- Fidelity Investments first reported a position in Passage Bio in Q1 2020 and held it in 20 quarters.
- Fidelity Investments's Passage Bio position peaked at $141M in Q1 2021.
- 41 funds tracked by Wall St. Rank held Passage Bio as of Q1 2025.
Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.